Additional information
| Active substance | Raloxifene Hydrochloride | 
|---|---|
| Water Retention | None | 
| Hepatotoxicity | Low risk | 
| Lab Test | Not specific, general liver function tests may be monitored | 
| Also known as | Raloxifene hydrochloride | 
| Blood pressure | Typically has no significant effect on blood pressure | 
| Trade name | Evista | 
| FORM | 100 tabs x 60 mg/tab | 
| Storage conditions | Store at room temperature, protect from moisture and heat | 
| Chemical name | [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl]-[4-[2-(1-piperidinyl)ethoxy]phenyl]methanone hydrochloride | 
| Formula | C28H27NO4SВ·HCl | 
| Substance class | Selective Estrogen Receptor Modulator (SERM) | 
| Main action | Estrogen receptor modulator | 
| Half-life | Approximately 27.7 hours | 
| Dosage (medical) | Commonly prescribed as 60 mg per day | 
| Dosage (sports) | Not typically used in sports for performance enhancement | 
| Effects | Reduces the risk of osteoporosis, decreases total and LDL cholesterol | 
| Side effects | Hot flashes, leg cramps, increased risk of venous thromboembolism, stroke | 
| Use in sports | None, as it is not known for performance enhancement | 
| Manufacturer | Dragon Pharma | 
 Alpha Pharma Mastebolin 100 mg 10 Amp-Masteron
							Alpha Pharma Mastebolin 100 mg 10 Amp-Masteron						 Avory Pharma Durabolin Phenylpropionat 100mg 10ml
							Avory Pharma Durabolin Phenylpropionat 100mg 10ml						 Femara Aaster Health and Sports Solutions
							Femara Aaster Health and Sports Solutions						

 
			 
			 
			 
			
Reviews
There are no reviews yet.